University of Ioannina
Διαταραχές της εμμήνου ρύσεως και τεκνοποίησης σε ασθενείς με καρκίνο του θυρεοειδή αδένα μετά από θεραπεία με Ι - 131
Abstract
dc:descriptionΕstrogen receptor alpha agonists increase and estrogen receptor beta agonists decrease the proliferation of thyroid cancer cells. The follicular cancer cells exhibit higher expression of the estrogen receptor alpha in women of pre-menopausal age compared to post-menopausal women and the differentiated thyroid cancer is more frequent in pre-menopausal women. The treatment of differentiated thyroid cancer includes a combination of surgical resection, radioactive Ι-131, and subsequent thyroid hormone replacement. Several menstrual cycle and reproductive disturbances have been described after therapy of thyroid cancer with radioiodine. It has been suggested that the absorbed radiation by the ovaries may result in possible temporary ovarian insufficiency and menstrual cycle disturbances in up to 12% - 31% of cases (usually temporary amenorrhea or alterations of the menstrual cycle). The specific aim of this study was to investigate the effects of radioactive I-131 in treated women of reproductive age with thyroid cancer on menstrual cycle regularity and amount of menstrual blood. In addition, it was investigated the effect of I-131 therapy on subsequent pregnancies and congenital malformations of children born after the therapy. Overall, 55 female patients ? 40 years old (range, 20-40) were included in this study. All patients received Ι-131 therapy after resection of the thyroid cancer. The mean follow-up period was 101.27 months (57-146). The administered total Ι-131 dose ranged between 80 to 500 mCi (mean 120.55 mCi). Most patients received only one treatment. The parameters that were examined included the frequency of menstrual cycle irregularities, such as the increase or decrease of the length of the cycle (in days), the increase or decrease of the days of menses and of the amount of the menstrual blood. In addition, all these changes were evaluated in relationship to age during the Ι-131 administration and the histologic type of cancer. Furthermore, the reproductive history of patients post treatment was examined in regard to total births, conception method, spontaneous or provoked abortions, birth weight, and presence of congenital malformations. Menstrual cell cycle length of 28 ± 4 days was considered within normal limits. The study results showed post-radioiodine abnormalities of the menstrual cycle or menses length and amount of menstrual blood in 38.2% of patients (21/55). Among them, 3/21 (14.3%) patients developed abnormalities only in length of menses or amount of menstrual blood, 4/21 patients (19%) only in menstrual cycle length, and 10/21 (47.6%) women in both. Two of 21 women (9.5%) had abnormalities before and after therapy and were excluded from the analysis. Thus, after exclusion of the 2 women with abnormalities before and after therapy 19/55 (34.5%) patients had menstrual cycle abnormalities related to therapy.In this cohort of patients, there were no congenital abnormalities of subsequently born children, or premature births or any other problems related to therapy in subsequent pregnancies. However, a small increase was noted in the number of spontaneous abortions as it has been noted in other studies without been able to reach statistical significance, possibly due to the small number of our patients. There was no indication of any decrease in fertility capability of our patients after the Ι-131 therapy. Thus, apart from a possible small increase in spontaneous abortions, there is no reason to advise females that have received Ι-131 for therapy of thyroid cancer against future pregnancy, although they should avoid pregnancy if possible during the first year post radioiodine therapy.
Degree
thesis:*- Grantor dc:publisher
- University of Ioannina
- Year dc:date
- 2009
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Sioka, Chrissa
- Σιόκα, Χρύσα
Subjects
dc:subject × 17- Καρκίνος θυρεοειδούς
- Εμμηνορυσιακός κύκλος
- Τεκνοποίηση
- Αυτόματες αποβολές
- Πρόωρος τοκετός
- Συγγενείς ανωμαλίες
- Ι - 131
- Thyroid cancer
- Menstrual cycle
- Fertility
- Spontaneous abortions
- Premature births
- Congenital abnormalities
- Ιατρική και Επιστήμες Υγείας
- Βασική Ιατρική
- Medical and Health Sciences
- Basic Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/17433